COMPANY
Warrior Labz SARMS
Warrior Labz SARMS: warning letter recipient for BPC-157, TB-500, as stated by public registers.
WARNING LETTER RECIPIENT
Received an FDA warning letter naming the peptide.
| BPC-157 | Unapproved New Drugs/Misbranded, 2023-06-12 Regulator FDA warning letters |
|---|---|
| TB-500 | Unapproved New Drugs/Misbranded, 2023-06-12 Regulator FDA warning letters |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.